6 Juni 2019

The Growing Wave of Biotech IPOs in China

Reforms within China affecting the biomedical industry, such as the accelerated review and approval of drugs, and the expansion of the reimbursement scheme

As the biotechnology industry becomes more global, companies must evaluate and adopt various cross-border strategic models to drive capital formation…

Full text: https://www.biotech-now.org/international/2019/05/the-growing-wave-of-biotech-ipos-in-china?utm_source=Feedburner&utm_medium=feed&utm_campaign=Feed%3A+BiotechNow+(BIOtech+Now)&utm_termn


Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email